BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2003
View Archived Issues
Ganstigmine safe in patients with probable Alzheimer's disease
Read More
NSAIDs evaluated for slowing the progression of Alzheimer's disease
Read More
Low response rate for SU-5416 in refractory myeloproliferative disorders
Read More
Improved glycemic control reported for nateglinide plus rosiglitazone in type 2 diabetes
Read More
Apafant effective in UVB-induced dermatitis
Read More
Wyeth claims three series of ERbeta-selective estrogenic agents for arthritis, IBD, etc.
Read More
Plant extract with gastric antisecretory activity patented by Korean researchers
Read More
Novel bone antiresorptive agents covered by Sankyo patent
Read More
New tachykinin NK1 antagonists prepared and tested at Schering-Plough
Read More
Novo Nordisk scientists present new glucagon antagonists/inverse agonists in recent patent
Read More
Roche describes new inhibitors of MDM2/p53 interaction with utility in cancer
Read More
Novel protein kinase inhibitors in early development at Abbott
Read More
South Korean scientists report synthesis and biological evaluation of promising antitumor retinoid
Read More
Caspase-dependent cell-killing and TRAIL-sensitizing effects reported for estrogen derivative
Read More
Discovery of potent, orally active, irreversible Her-2 receptor tyrosine kinase inhibitor reported
Read More
A-409100, a second-generation FTase inhibitor with a promising preclinical profile
Read More
Selective chemotherapy with SDX-102 in MTAP-deficient tumors
Read More
Positive safety results emerge from phase I/II study of Theralux
Read More
4SC and Esteve broaden their research partnership
Read More
AMD-3100 granted orphan drug status for stem cell transplantation in cancer patients
Read More
Boehringer Ingelheim and Medivir sign agreement for MIV-310
Read More
FDA advisory panel to review Onyx for the treatment of certain neurovascular disorders
Read More
Roche SARS test now available
Read More
Curacyte discovers new antitumor agents
Read More
Antiangiogenic/antitumor VEGFR kinase inhibitor with an anthranilamide structure
Read More